DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
BMS-698769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
BMS-698769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG-7603
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Serine/threonine-protein kinase mTOR inhibitor
RG-7603
×
Maximum Phase:
1
First Approval:
None
UNII:
579255I6O9
Molecule Type:
Small molecule
Molecular Formula:
C24H32N6O3
Molecular Weight:
452.56
AlogP:
2.27
PSA:
91.85
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NONA-L-ARGININE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NONA-L-ARGININE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
JNJ-38877605
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Hepatocyte growth factor receptor inhibitor
JNJ-38877605
×
Maximum Phase:
1
First Approval:
None
UNII:
15UDG410PN
Molecule Type:
Small molecule
Molecular Formula:
C19H13F2N7
Molecular Weight:
377.36
AlogP:
3.21
PSA:
73.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
MK-0752
1
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Neoplasms
Unknown
MK-0752
×
Maximum Phase:
1
First Approval:
None
UNII:
9JD9B4S53T
Molecule Type:
Small molecule
Molecular Formula:
C21H21ClF2O4S
Molecular Weight:
442.91
AlogP:
5.34
PSA:
71.44
HBD:
1.0
HBA:
#RotB:
6.0
Source:
LOTRAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LOTRAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEMANOGREL
1
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Serotonin 2a (5-HT2a) receptor inverse agonist
TEMANOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
DEFERITRIN
1
Small molecule
Investigational
Unknown
Unknown
beta-Thalassemia
Unknown
DEFERITRIN
×
Maximum Phase:
1
First Approval:
None
UNII:
T69Y9LDN44
Molecule Type:
Small molecule
Molecular Formula:
C11H11NO4S
Molecular Weight:
253.28
AlogP:
1.43
PSA:
90.12
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ASP-5878
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ASP-5878
×
Maximum Phase:
1
First Approval:
None
UNII:
C0Z095LL72
Molecule Type:
Small molecule
Molecular Formula:
C18H19F2N5O4
Molecular Weight:
407.38
AlogP:
2.28
PSA:
103.55
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ORE-1001
1
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
ORE-1001
×
Maximum Phase:
1
First Approval:
None
UNII:
4LD0ZHV25K
Molecule Type:
Small molecule
Molecular Formula:
C19H23Cl2N3O4
Molecular Weight:
428.32
AlogP:
3.32
PSA:
104.45
HBD:
3.0
HBA:
#RotB:
10.0
Source:
A27.15
1
Antibody
Investigational
Unknown
Unknown
Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders
Transferrin receptor protein 1 antagonist
A27.15
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK2879552
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes; Small Cell Lung Carcinoma
Unknown
GSK2879552
×
Maximum Phase:
1
First Approval:
None
UNII:
GT77Z6Y09Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O2
Molecular Weight:
364.49
AlogP:
3.74
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
ANHYDROVINBLASTINE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ANHYDROVINBLASTINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NIKKOMYCIN
1
Small molecule
Investigational
Unknown
Unknown
Coccidioidomycosis
Unknown
NIKKOMYCIN
×
Maximum Phase:
1
First Approval:
None
UNII:
9Z22C3QQCJ
Molecule Type:
Small molecule
Molecular Formula:
C20H25N5O10
Molecular Weight:
495.45
AlogP:
-3.48
PSA:
250.32
HBD:
8.0
HBA:
#RotB:
8.0
Source:
AMG-427
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
AMG-427
×
Maximum Phase:
1
First Approval:
None
UNII:
P9I9Z3MF7Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIPRALISANT MALEATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Histamine H3 receptor agonist
CIPRALISANT MALEATE
×
Maximum Phase:
1
First Approval:
None
UNII:
7ENI812SZS
Molecule Type:
Small molecule
Molecular Formula:
C18H24N2O4
Molecular Weight:
332.4
AlogP:
3.34
PSA:
28.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
DIROCAFTOR
1
Small molecule
Investigational
Unknown
Unknown
Cystic Fibrosis
Unknown
DIROCAFTOR
×
Maximum Phase:
1
First Approval:
None
UNII:
2G3T6M1AS9
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O3Si2
Molecular Weight:
424.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MLN-591RL
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MLN-591RL
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GS-9901
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular
Unknown
GS-9901
×
Maximum Phase:
1
First Approval:
None
UNII:
U09Q76B8VK
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClFN9O
Molecular Weight:
477.89
AlogP:
2.96
PSA:
161.42
HBD:
3.0
HBA:
#RotB:
5.0
Source:
AMG-224
1
Unknown
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
AMG-224
×
Maximum Phase:
1
First Approval:
None
UNII:
Y69B45U0TK
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ON123300
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ON123300
×
Maximum Phase:
1
First Approval:
None
UNII:
QJ8RO3296G
Molecule Type:
Small molecule
Molecular Formula:
C24H27N7O
Molecular Weight:
429.53
AlogP:
3.27
PSA:
90.08
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MURIZATOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes
Unknown
MURIZATOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C42H57ClN4O5S
Molecular Weight:
765.46
AlogP:
6.44
PSA:
91.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PHENFORMIN
1
Small molecule
Investigational
Unknown
Unknown
Melanoma; Diabetes Mellitus
Unknown
PHENFORMIN
×
Maximum Phase:
1
First Approval:
None
UNII:
DD5K7529CE
Molecule Type:
Small molecule
Molecular Formula:
C10H15N5
Molecular Weight:
205.26
AlogP:
0.24
PSA:
97.78
HBD:
5.0
HBA:
#RotB:
3.0
Source:
BLXA4
1
Small molecule
Investigational
Unknown
Unknown
Inflammation
Unknown
BLXA4
×
Maximum Phase:
1
First Approval:
None
UNII:
LXE89WJ787
Molecule Type:
Small molecule
Molecular Formula:
C22H32O5
Molecular Weight:
376.49
AlogP:
3.63
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
13.0
Source:
AM-211
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
AM-211
×
Maximum Phase:
1
First Approval:
None
UNII:
SZB129M7SZ
Molecule Type:
Small molecule
Molecular Formula:
C27H27F3N2O4
Molecular Weight:
500.52
AlogP:
5.74
PSA:
78.87
HBD:
2.0
HBA:
#RotB:
9.0
Source:
SEVITERONEL
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Breast Neoplasms, Male; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
SEVITERONEL
×
Maximum Phase:
1
First Approval:
None
UNII:
8S5OIN36X4
Molecule Type:
Small molecule
Molecular Formula:
C18H17F4N3O3
Molecular Weight:
399.34
AlogP:
4.05
PSA:
80.26
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MIRZOTAMAB CLEZUTOCLAX
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
MIRZOTAMAB CLEZUTOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
TY49T0B03B
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XL-844
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
XL-844
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-4769
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
AZD-4769
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H27NO3S
Molecular Weight:
457.6
AlogP:
6.7
PSA:
59.42
HBD:
1.0
HBA:
#RotB:
11.0
Source:
NEOSAXITOXIN
1
Small molecule
Investigational
Unknown
Unknown
Pain
Unknown
NEOSAXITOXIN
×
Maximum Phase:
1
First Approval:
None
UNII:
6YRL8BWD9H
Molecule Type:
Small molecule
Molecular Formula:
C10H17N7O5
Molecular Weight:
315.29
AlogP:
-3.54
PSA:
193.75
HBD:
7.0
HBA:
#RotB:
2.0
Source:
SNS-062
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SNS-062
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRL-1620
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
IRL-1620
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BPN-14967
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BPN-14967
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1795091
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
GSK-1795091
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
108
109
110
111
112
113
114
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA